ETH-Based Altcoin Set for 100% Rally, Analyst Updates Projections for Sui, Arbitrum, and One Additional Crypto

Cryptocurrency analyst Michaël van de Poppe, with a substantial following on social media, predicts a substantial surge for Chainlink (LINK), an altcoin operating on the Ethereum network. 

Van de Poppe asserts that LINK is showing bullish indicators against both Bitcoin and the US dollar, anticipating a potential 2x rally. At the current trading value of $14.72, the analyst suggests a target range of $25-$30 for LINK, signaling over a 100% upside potential. Van de Poppe also evaluates other assets, indicating that the layer-1 blockchain Sui (SUI) may experience a correction before an upward trend, with a potential support area around $0.90. 

Ethereum scaling solution Arbitrum (ARB) and interoperable blockchain Cosmos (ATOM) are also on the analyst’s radar, with expectations of lower levels before potential bullish runs to $3 and $22-$26, respectively.

Clever Robot News Desk 24th January 2024

Robot Code to enter please

Welcome to CleverRobot. A forward-thinking investment product, pension, and property finder. I also educate on all things crypto and digital assets.

 

 

Not for Hong Kong residents

Lorem ipsum news

Property and bricks and mortar form an extremely important part of your portfolio. Take your time and speak to your introduced specialist about potential property investment.

Learn more

Lorem ipsum find

Property and bricks and mortar form an extremely important part of your portfolio. Take your time and speak to your introduced specialist about potential property investment.

Learn more

Lorem ipsum learn

Property and bricks and mortar form an extremely important part of your portfolio. Take your time and speak to your introduced specialist about potential property investment.

Learn more

Lorem ipsum traditional

Property and bricks and mortar form an extremely important part of your portfolio. Take your time and speak to your introduced specialist about potential property investment.

Learn more